Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
CNS Neuroscience & Therapeutics|June 18, 2010
Seeking brain biomarkers for preventive therapy in Huntington diseaseMouna Esmaeilzadeh, Andrea Ciarmiello, Ferdinando SquitieriLakartidningen|May 29, 2020
[Rapid point-of-care serology testing for sars-cov-2]Otto Stackelberg, Mouna Esmaeilzadeh, Björn Olsen, et al.Clinical Neuropharmacology|May 19, 2011
Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington diseaseMouna Esmaeilzadeh, Johan Kullingsjö, Henrik Ullman, et al.Journal of Cellular Physiology|October 15, 2010
PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic researchGiampiero Giovacchini, Ferdinando Squitieri, Mouna Esmaeilzadeh, et al.Human Brain Mapping|October 2, 2010
Extrastriatal dopamine D(2) receptor binding in Huntington's diseaseMouna Esmaeilzadeh, Lars Farde, Per Karlsson, et al.Infection Ecology & Epidemiology|May 5, 2020
Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2Tove Hoffman, Karolina Nissen, Janina Krambrich, et al.Infection Ecology & Epidemiology|September 17, 2020
High seroprevalence of SARS-CoV-2 in elderly care employees in SwedenJohanna F Lindahl, Tove Hoffman, Mouna Esmaeilzadeh, et al.Synapse (New York, N.Y.)|December 4, 2009
Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouseAxel Rominger, Erika Wagner, Erik Mille, et al.Pageof 1